Lactation Flashcards
Mammary glands
Highly modified tubuloalveolar apocrine sweat glands Structure: Breast lobe 15-25 compound tubule-acinar glands of variable size Within each lobe: Lobules Multiple acini Terminal ducts Drain each lobule Lactiferous duct Drains terminal ducts Lactiferous sinus A dilation in the duct immediately before the opening Intralobular stroma Hormonally responsive CT, little adipose Interlobular tissue Dense regular CT and adipose tissue
Terminal duct lobular unit (TDLU)
Grapelike cluster of alveoli with terminal ducts and intralobular stroma
Connective tissue
- Loose, collagen rich with dispersed adipose cells
Cells
- Luminal epithelial cells (Columnar to cuboidal)
Myoepithelial cells
-Flattened, basal
Inactive versus active mammary glands
Inactive
Stroma constitute the major portion of lobules
Luminal epithelium columnar, dispersed chromatin
Active
Proliferation of the duct system
Alveoli constitute the major portion of lobules
Luminal epithelium cuboidal, pale cytoplasm, prominent nucleoli
Nipple Parts
Areola, Areolar sebaceous glands, lactiferous ducts, bundles of smooth muscles
Areola
Pigmented skin (melanocytes)
Stratified squamous keratinized epithelium
Dermal papillae
Lactiferous ducts
Transitioning epithelium From the lactiferous duct - Single layer of columnar or cuboidal Within the lactiferous duct - Stratified cuboidal Near duct opening - Stratified squamous keratinized epithelium
Breast cancer
80% are invasive ductal carcinoma
Carcinomas (Arise from epithelium:
Ductal- Within the duct, Lobular- Within the terminal acini)
Sarcomas
- Arise from stroma
In situ
- Has not yet invaded breast tissue, resides inside pre-existing lobules or ducts
Invasive
- Cells infiltrate breast connective tissue
Hormone receptor status
Determines responsiveness to therapeutic interventions
- Estrogen-receptor positive (ER+)
- Human epidermal growth factor expression (HER-2/neu+)
- Progesterone-receptor positive (PR+)
Triple negative
Invasive Breast Cancer: Breast Epithelium
(primarily ductal) Highly mitogenic Hormonally responsive Primarily Estrogen (~75% E+, 65% of E+ are also PR+)
CYP19 aromatase inhibitor
Inhibits peripheral conversion: androgen –> estrogen
(postmenopausal)
Selective Estrogen Receptor Modulator (SERM)
(E.g.: Tamoxifen, agonist at bone and uterus; antagonist at breast)
(premenopausal)
Estrogens/Progesterone
Fetoplacental production
Mammogenic
Continue to rise throughout pregnancy
Prolactin (PRL)
Secreted by anterior pituitary gland during pregnancy
Mammogenic, lactogenic
↑ 10-20x from ~ 5th week until parturition
Estrogen stimulates production & inhibits action
Human chorionic somatomammotropin (hCS)/ Human placental lactogen (hPL)
- Structurally similar to PRL and GH
- Produced by the placenta
- Lactogenic
State of lactation hormones near end of pregnancy
Near end of pregnancy:
breasts are fully developed but milk production is suppressed except for small amount of colostrum
- Inhibited by high estrogen & progesterone during pregnancy
Oxytocin
Neurohypophyseal hormone
Produced during parturition
Stimulates uterine contractions
Promotes contraction of myoepithelial cells resulting in milk ejection (“let-down”)
↑ oxytocin synthesis and release via positive feedback caused by suckling, anticipation of nursing, and audiovisual stimuli
Four Stages of Lactation
Milk Synthesis
Initiated by PRL and hPL in later pregnancy
- Lactogenesis
Milk synthesis by alveolar cells and secretion into alveolar lumen
Initiated after birth by the loss of placental steroids - Galactopoiesis
Maintenance of established lactation
Mainly controlled by PRL which is increased by infant suckling - Milk Ejection
Passage of milk to the duct system, collection in ampulla and larger ducts, and delivery to infant
Controlled by oxytocin release stimulated by suckling, anticipation of nursing, and audiovisual stimuli